Infectious Disease and Microbiology – Onchocerca volvulus

Overview

Onchocerca volvulus is a filarial nematode that causes onchocerciasis, also known as river blindness. The infection is transmitted exclusively by the bite of infected blackflies of the genus Simulium.

Adult worms typically live within subcutaneous nodules, while their offspring, the microfilariae, migrate through the skin and ocular tissues. Much of the clinical disease results from inflammatory responses to dying microfilariae, producing chronic dermatitis, skin changes, and potentially severe ocular damage leading to visual impairment or blindness.

Classification

Genus: Onchocerca

Species: Onchocerca volvulus

Type: Filarial nematode helminth

Disease: Onchocerciasis

Classic name: River blindness

Vector: Simulium blackfly

Microbiologic Characteristics

O. volvulus is a:

• Nematode helminth

• Filarial worm

• Vector-borne parasite

• Tissue-dwelling parasite

The adult worms reside mainly within:

Subcutaneous fibrous nodules

while microfilariae migrate through:

Skin and ocular tissues

Important Parasitologic Pattern

Adult worms

→ Subcutaneous nodules

Microfilariae

→ Skin and eyes

This tissue distribution is extremely important for diagnosis and understanding the clinical manifestations.

Incubation Period

The interval from inoculation of infective larvae until microfilariae can be detected in the skin is approximately:

6–12 months

Because adult worms can survive for years, infection can become chronic and produce prolonged disease.

Epidemiology

Onchocerciasis has historically occurred particularly in:

• Sub-Saharan Africa

• Yemen

• Parts of the Arabian Peninsula

• Historically, limited foci in Central and South America

The greatest disease burden has traditionally occurred in:

Sub-Saharan Africa

Why Is It Called River Blindness?

The vector:

Simulium blackfly

breeds in:

Fast-flowing rivers and streams

Therefore, communities living near suitable river systems may experience repeated blackfly exposure and transmission.

This relationship between:

River → blackfly → Onchocerca → blindness

gave rise to the term:

River blindness

Transmission

Human infection occurs through the bite of an infected:

Simulium blackfly

The fly introduces infective larvae into the skin during feeding.

Life Cycle

Infected Simulium blackfly bites human

↓

Deposits infective larvae into skin

↓

Larvae mature into adult worms

↓

Adults become enclosed within:

Subcutaneous nodules (onchocercomas)

↓

Female worms release:

Microfilariae

↓

Microfilariae migrate through:

Skin and eyes

↓

Another blackfly takes a blood meal

↓

Ingests microfilariae

↓

Larvae develop within blackfly

↓

Blackfly transmits infection to another person

High-Yield Transmission Pattern

Fast-flowing river

• ●

Simulium blackfly

• ●

Filarial nematode

→ Think Onchocerca volvulus

Onchocerciasis

The disease caused by O. volvulus is:

Onchocerciasis

It is typically a:

Chronic filarial infection

The two major organ systems affected are:

Skin

and

Eyes

Subcutaneous Nodules

Adult worms are found within fibrous subcutaneous nodules called:

Onchocercomas

These nodules are often firm and may contain multiple adult worms.

Distribution of Nodules

The location of nodules may vary geographically and according to exposure.

They frequently develop over:

• Bony prominences

• Pelvic regions

• Lower extremities

• Trunk

• Head

Their presence in a patient from an endemic area provides an important diagnostic clue.

Cutaneous Onchocerciasis

Microfilariae migrate extensively through the:

Dermis

Their presence and death provoke inflammatory reactions that can produce chronic skin disease.

Dermatologic Manifestations

Possible findings include:

• Intense pruritus

• Papular dermatitis

• Chronic inflammatory skin lesions

• Hyperpigmentation

• Hypopigmentation

• Skin thickening

• Skin atrophy

• Loss of elasticity

Long-standing infection may produce characteristic chronic skin changes.

Leopard Skin

Chronic infection may cause patchy areas of:

Depigmentation

particularly over the lower extremities.

This appearance is traditionally called:

“Leopard skin”

and is a classic association with onchocerciasis.

Ocular Onchocerciasis

The most feared complication occurs when:

Microfilariae migrate into ocular tissues

Inflammation caused by the parasites can progressively damage structures of the eye.

Ocular Manifestations

Potential manifestations include:

• Keratitis

• Anterior uveitis

• Chorioretinitis

• Optic nerve involvement

• Progressive visual impairment

• Blindness

River Blindness

The sequence can be remembered as:

Microfilariae enter eye

↓

Microfilariae die

↓

Intense inflammatory response

↓

Repeated/chronic ocular inflammation

↓

Corneal and retinal injury

↓

Progressive visual loss

↓

Blindness

High-Yield Clinical Pattern

Patient from an endemic African region

• ●

Exposure near fast-flowing rivers

• ●

Pruritic chronic dermatitis

• ●

Subcutaneous nodules

• ●

Progressive visual impairment

→ Think Onchocerca volvulus

→ River blindness

Diagnosis

The classic diagnostic method is:

Skin snip microscopy

A small superficial skin biopsy is placed in:

Water or saline

allowing microfilariae to emerge from the tissue.

Skin Snip Examination

Superficial skin biopsy

↓

Incubate in saline/water

↓

Microfilariae emerge

↓

Microscopic identification

This is a classic diagnostic method for onchocerciasis.

Slit-Lamp Examination

A:

Slit-lamp eye examination

can demonstrate microfilariae or characteristic ocular abnormalities.

It is particularly useful when ocular involvement is suspected.

Examination of Nodules

Adult worms can be demonstrated by:

Excision and examination of subcutaneous nodules

This may confirm the presence of O. volvulus adults.

Serology

Serologic testing may support diagnosis, but the source emphasizes that it is:

Nonspecific

because antibodies may cross-react with other:

Filarial infections

Therefore, serology alone may not reliably establish active O. volvulus infection.

Treatment

The major drug used for onchocerciasis is:

Ivermectin

Ivermectin primarily acts against:

Microfilariae

and markedly reduces the number of microfilariae in the skin and eyes.

Why Repeated Treatment Is Needed

Ivermectin is highly effective at suppressing microfilariae but does not reliably eliminate all long-lived adult worms after a single treatment.

Therefore:

Ivermectin

↓

Microfilariae markedly reduced

↓

Adult female worms remain

↓

Microfilariae can eventually reappear

↓

Repeat treatment is necessary

The source recommends retreatment approximately:

Every 6–12 months

Doxycycline and Wolbachia

An important biologic feature of O. volvulus is its association with intracellular bacteria of the genus:

Wolbachia

These bacterial endosymbionts are important for the fertility and survival of the worms.

Treatment with:

Doxycycline

can target Wolbachia, impairing adult female worm fertility and contributing to longer-term control in selected patients.

Treatment Concept

Ivermectin

→ Rapidly reduces microfilariae

Doxycycline

→ Targets Wolbachia endosymbionts

→ Reduces adult worm fertility and viability

These therapies therefore affect the infection through different mechanisms.

Caution with Loa loa Coinfection

A critical treatment consideration is possible coinfection with:

Loa loa

This is particularly relevant in parts of Central and West Africa where the geographic distributions overlap.

Why Loa loa Matters

Patients with very high Loa loa microfilarial burdens may develop:

Severe neurologic adverse reactions

after ivermectin treatment.

Therefore:

Possible Loa loa exposure

• ●

High microfilarial burden

→ Requires careful assessment before ivermectin therapy.

High-Yield Safety Pattern

African patient with suspected onchocerciasis

• ●

Potential Loa loa coinfection

→ Assess carefully before ivermectin

because heavy loiasis increases the risk of serious treatment-related neurologic complications.

Diethylcarbamazine

The source advises that:

Diethylcarbamazine (DEC) should not be used for onchocerciasis

because rapid killing of large numbers of microfilariae can trigger severe inflammatory reactions.

This is an important distinction from several other filarial infections in which DEC may have a therapeutic role.

Suramin

The source lists:

Suramin

as an additional historical treatment.

However, it can cause significant toxicity, including:

Nephrotoxicity

and therefore requires close medical supervision. It is not the routine first-line approach when safer effective strategies are available.

Onchocerca vs. Loa loa

Onchocerca volvulus

→ Simulium blackfly

→ Fast-flowing rivers

→ Microfilariae primarily in skin

→ Subcutaneous nodules

→ Dermatitis

→ River blindness

→ Ivermectin is central therapy

Loa loa

→ Chrysops deer fly

→ Central/West African rainforest

→ Microfilariae primarily in blood

→ Calabar swellings

→ Adult worm may migrate across conjunctiva

→ High microfilarial burden creates special risk with ivermectin

Onchocerca vs. Wuchereria bancrofti

Onchocerca volvulus

→ Microfilariae in skin

→ Simulium blackfly

→ Dermatitis and blindness

→ Subcutaneous nodules

Wuchereria bancrofti

→ Microfilariae in blood

→ Mosquito vector

→ Lymphatic system involvement

→ Lymphedema and elephantiasis

Diagnostic Memory Aid

Onchocerca

→ SKIN snip

Wuchereria

→ BLOOD

This reflects the typical location of the microfilariae used for diagnosis.

Prevention

Prevention focuses on reducing exposure to:

Simulium blackfly bites

Measures include:

• Protective clothing

• Appropriate insect repellents

• Vector-control programs

• Community-based parasite-control programs in endemic regions

Community Control

Because humans serve as an important reservoir for transmission, repeated community-wide treatment with:

Ivermectin

can reduce skin microfilarial loads and consequently decrease transmission to blackflies.

Large-scale control programs have substantially reduced disease in many endemic areas.

High-Yield Clinical Pattern

Sub-Saharan Africa

• ●

Fast-flowing river exposure

• ●

Simulium blackfly

• ●

Subcutaneous nodules

• ●

Pruritic dermatitis

• ●

Microfilariae in skin

• ●

Progressive blindness

→ Think Onchocerca volvulus

→ ONCHOCERCIASIS / RIVER BLINDNESS

Exam Essentials

Organism: Onchocerca volvulus

Type: Filarial nematode

Disease: Onchocerciasis

Classic name: River blindness

Major endemic region: Sub-Saharan Africa

Vector: Simulium blackfly

Vector habitat: Fast-flowing rivers and streams

Transmission: Bite of infected blackfly

Incubation to skin microfilariae: Approximately 6–12 months

Adult worm location: Subcutaneous nodules (onchocercomas)

Microfilariae: Primarily skin and eyes

Major skin symptom: Pruritus

Classic chronic skin finding: “Leopard skin” depigmentation

Major ocular complication: Blindness

Classic diagnosis: Skin snip demonstrating microfilariae

Eye evaluation: Slit-lamp examination

Serology: May cross-react with other filarial infections

Treatment: Ivermectin with repeated dosing

Important endosymbiont: Wolbachia

Additional therapeutic approach: Doxycycline targeting Wolbachia in appropriate patients

Major ivermectin caution: Loa loa coinfection with high microfilarial burden

DEC: Generally avoided in onchocerciasis because of potentially severe inflammatory reactions

Historical alternative: Suramin, limited by significant toxicity

Prevention: Blackfly avoidance, vector control, and community treatment programs

Key clinical pearl: Onchocerca volvulus is transmitted by Simulium blackflies breeding near fast-flowing rivers. Adult worms live in subcutaneous nodules, while microfilariae migrate through the skin and eyes, producing severe pruritic dermatitis and potentially irreversible “river blindness.” Diagnose classically with a skin snip and treat primarily with repeated ivermectin, while remembering the crucial danger of ivermectin in patients with very high Loa loa microfilarial burdens.

Infectious Disease and Microbiology – Oligella Species

Overview

Oligella species are rare Gram-negative coccobacilli that are most commonly recovered from the urinary tract. The two principal species are Oligella ureolytica and Oligella urethralis.

These organisms are uncommon causes of human disease, but they may occasionally produce urinary tract infections (UTIs), particularly when recovered from a patient with compatible urinary symptoms.

Classification

Genus: Oligella

Important species include:

• Oligella ureolytica

• Oligella urethralis

Microbiologic Characteristics

The source describes Oligella species as:

• Gram-negative

• Coccobacillary in morphology

• Associated predominantly with the genitourinary tract

They are relatively uncommon organisms in routine clinical microbiology.

High-Yield Microbiology Pattern

Gram-negative coccobacillus

• ●

Predominantly isolated from urine

• ●

Rare human pathogen

→ Consider Oligella species

Incubation Period

The incubation period for Oligella infection is:

Unknown

Because these organisms are rarely implicated in clinical disease, the natural history and incubation period have not been well characterized.

Epidemiology

Most clinical isolates of Oligella species have been recovered from:

Urine specimens

This strong association with urine and the genitourinary tract explains why the principal recognized clinical syndrome is:

Urinary tract infection

Clinical Significance

Because Oligella is an unusual clinical isolate, its significance should be interpreted in the context of:

• Urinary symptoms

• Urinalysis findings

• Quantitative or repeated urine cultures

• Patient risk factors

• Presence of urinary instrumentation or abnormalities

Isolation from urine does not necessarily establish infection in the absence of compatible clinical findings.

Urinary Tract Infection

The major infection associated with Oligella species is:

Urinary tract infection

Human infection remains rare.

Clinical Manifestations

When Oligella produces a symptomatic lower urinary tract infection, manifestations may include:

• Dysuria

• Urinary frequency

• Urinary urgency

• Suprapubic discomfort

• Abnormal urinalysis

More complicated urinary infection may produce systemic manifestations such as fever, depending on the site and severity of infection.

Predisposing Factors

As with other unusual urinary pathogens, clinically significant infection may be more likely in patients with:

• Urinary tract abnormalities

• Urinary obstruction

• Indwelling urinary catheters

• Recent urinary instrumentation

• Significant underlying disease

The clinical context is particularly important when deciding whether an uncommon urinary isolate represents infection.

High-Yield Clinical Pattern

Patient with urinary symptoms

• ●

Urine culture grows an unusual Gram-negative coccobacillus

• ●

Organism identified as Oligella

→ Consider Oligella-associated UTI

Diagnosis

The primary diagnostic method is:

Culture

The organism is most commonly recovered from:

Urine culture

Interpretation of Culture

Because Oligella is rarely encountered, laboratory identification should be interpreted together with evidence of urinary tract inflammation and symptoms.

Repeated recovery from properly collected specimens strengthens the evidence that the organism is clinically significant.

Treatment

There are:

Very limited data

regarding the antimicrobial susceptibility and optimal treatment of Oligella infections.

The source indicates that:

Penicillin may be effective

against susceptible isolates.

Additional Treatment

The source also lists:

Cephalosporins

as potential therapeutic agents.

Susceptibility-Guided Therapy

Because antimicrobial susceptibility patterns are not as well established as those of common urinary pathogens, an important management principle is:

Culture

↓

Species identification

↓

Antimicrobial susceptibility testing when available

↓

Select an active antimicrobial

Treatment should therefore be individualized rather than assuming uniform susceptibility across all Oligella isolates.

Oligella ureolytica

Oligella ureolytica is one of the two major species associated with humans.

Its name reflects an important biochemical characteristic:

Urease activity

The organism has been recovered predominantly from the genitourinary tract and can occasionally cause urinary infection.

Oligella urethralis

Oligella urethralis is also associated primarily with the:

Genitourinary tract

and may occasionally be recovered from urine specimens.

Like O. ureolytica, it is only rarely implicated as a cause of clinically significant infection.

Oligella vs. Common Urinary Pathogens

Oligella

→ Rare urinary pathogen

→ Gram-negative coccobacillus

→ Most isolates recovered from urine

→ Limited antimicrobial susceptibility data

Escherichia coli

→ Most common cause of community-acquired UTI

→ Gram-negative bacillus

→ Well-established pathogenic role

Proteus

→ Gram-negative bacillus

→ Strong urease activity

→ Associated with alkaline urine and struvite stones

Therefore, identification of Oligella in urine represents a much less common microbiologic finding than isolation of typical uropathogens.

Prevention

There are no specific preventive measures directed uniquely against Oligella species.

General prevention of complicated urinary infection includes:

• Appropriate urinary catheter care

• Avoiding unnecessary catheterization

• Proper aseptic technique during urinary instrumentation

• Prompt management of urinary obstruction when clinically indicated

High-Yield Clinical Pattern

Rare Gram-negative coccobacillus

• ●

Predominantly recovered from urine

• ●

Urinary tract infection

• ●

Limited antimicrobial susceptibility data

→ Think Oligella species

Exam Essentials

Genus: Oligella

Major species: O. ureolytica and O. urethralis

Morphology: Gram-negative coccobacillus

Incubation period: Unknown

Major specimen: Urine

Clinical importance: Rare human pathogen

Major infection: Urinary tract infection

Diagnosis: Culture

Antimicrobial data: Very limited

Source treatment: Penicillin may be effective

Additional source treatment: Cephalosporin

Preferred management principle: Susceptibility-guided antimicrobial therapy because susceptibility may vary

O. ureolytica: Associated with urease activity

Prevention: General urinary catheter and instrumentation infection-control measures

Key clinical pearl: Oligella species are rare Gram-negative coccobacilli encountered predominantly in urine. When O. ureolytica or O. urethralis is recovered from a patient with compatible urinary symptoms, consider a true UTI, but interpret the culture carefully because these organisms are uncommon and antimicrobial susceptibility data are limited; treatment should ideally be guided by susceptibility testing.

Infectious Disease and Microbiology – Ochrobactrum anthropi

Overview

Ochrobactrum anthropi is an aerobic, Gram-negative bacillus that is widely distributed in the environment and is an uncommon opportunistic human pathogen. It is particularly associated with healthcare-associated bloodstream infections involving indwelling intravascular devices, especially central venous catheters.

Although bacteremia is the most characteristic infection, O. anthropi has also been reported to cause peritonitis, septic arthritis, and other invasive infections, particularly in patients with underlying illness or implanted medical devices.

Classification

Genus: Ochrobactrum

Species: Ochrobactrum anthropi

Organism type: Gram-negative bacillus

Clinical role: Opportunistic environmental pathogen

Microbiologic Characteristics

O. anthropi is:

• Gram-negative

• Bacillary in morphology

• Aerobic

• Environmental

• Opportunistic

It is a nonfermenting Gram-negative organism and can survive in environmental and healthcare-associated settings.

High-Yield Microbiology Pattern

Aerobic Gram-negative bacillus

• ●

Environmental organism

• ●

Opportunistic infection

• ●

Indwelling vascular catheter

→ Consider Ochrobactrum anthropi

Incubation Period

The incubation period for O. anthropi infection is:

Unknown

The timing of infection depends largely on the type of exposure, presence of an invasive device, and host factors.

Epidemiology

O. anthropi is a:

Rare cause of human infection

The organism has been recovered from numerous:

• Environmental sources

• Healthcare environments

• Human clinical specimens

Its environmental distribution provides opportunities for contamination of medical equipment or devices.

Risk Factors

Clinically significant infection is most strongly associated with:

• Central venous catheters

• Other indwelling medical devices

• Prolonged hospitalization

• Immunocompromised states

• Serious underlying disease

• Repeated invasive procedures

Central Venous Catheter-Related Bacteremia

The major infection associated with O. anthropi is:

Central venous catheter-related bloodstream infection

The organism can adhere to artificial surfaces and persist in association with intravascular devices.

Clinical Manifestations

Catheter-associated bacteremia may present with:

• Fever

• Chills

• Malaise

• Positive blood cultures

• Sepsis in more severe cases

Persistent or recurrent bacteremia should raise concern for an infected catheter or another colonized device.

High-Yield Clinical Pattern

Hospitalized or medically complex patient

• ●

Central venous catheter

• ●

Unexplained bacteremia

• ●

Environmental Gram-negative bacillus isolated from blood

→ Consider Ochrobactrum anthropi

Device-Associated Infection

A major principle in O. anthropi infection is its association with:

Foreign material

Therefore, treatment may require not only appropriate antimicrobial therapy but also:

Removal or replacement of the infected device

when clinically indicated.

Peritonitis

The source reports:

Peritonitis

as another manifestation of O. anthropi infection.

Device-associated peritonitis may occur particularly in patients undergoing:

Peritoneal dialysis

although this remains an uncommon infection.

Septic Arthritis

O. anthropi has also been reported as a rare cause of:

Septic arthritis

Patients may present with:

• Joint pain

• Swelling

• Restricted movement

• Fever

• Inflammatory synovial fluid

Diagnosis depends on recovery of the organism from appropriate clinical specimens.

Other Invasive Infections

Although uncommon, O. anthropi can occasionally produce other opportunistic infections.

The significance of an isolate should therefore be interpreted according to:

• Site of isolation

• Repeated positive cultures

• Presence of compatible symptoms

• Presence of invasive devices

• Host immune status

Diagnosis

The primary diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Blood

• Catheter-associated specimens

• Peritoneal fluid

• Synovial fluid

• Other normally sterile-site specimens

Blood Cultures

For suspected catheter-related infection:

Blood cultures

are particularly important.

Recovery of O. anthropi from multiple blood cultures in a patient with an intravascular catheter supports the diagnosis of clinically significant bacteremia rather than incidental contamination.

Identification

Laboratory identification is important because uncommon nonfermenting Gram-negative bacilli may sometimes be difficult to differentiate using traditional biochemical methods.

Modern laboratory methods can improve species-level identification.

Treatment

The source lists:

Trimethoprim–sulfamethoxazole (TMP-SMX)

as the primary treatment option.

Additional Treatment Options

The source also lists:

• Imipenem

• Aminoglycosides

• Fluoroquinolones

However, antimicrobial susceptibility can vary, so therapy should ideally be:

Guided by susceptibility testing

Antimicrobial Resistance

An important characteristic of O. anthropi is that it may demonstrate resistance to multiple antimicrobial agents.

In particular, resistance to several:

β-lactam antibiotics

can occur.

Therefore, treatment should not be selected solely on the basis of the organism being a Gram-negative bacillus.

Treatment Principle

Culture-confirmed O. anthropi infection

↓

Perform antimicrobial susceptibility testing

↓

Select an active antimicrobial

• ●

Evaluate for an infected:

Catheter or other foreign body

↓

Remove or replace infected device when indicated

Source Control

For catheter-associated bacteremia, an important management principle is:

Source control

Persistent bacteremia may be difficult to eradicate if the colonized catheter remains in place.

Therefore:

Antimicrobial therapy

• ●

Appropriate catheter management

may be necessary for successful treatment.

Prevention

Because O. anthropi infections are frequently healthcare- and device-associated, prevention focuses on:

• Strict aseptic technique during catheter insertion

• Proper catheter maintenance

• Hand hygiene

• Appropriate disinfection procedures

• Avoiding unnecessary prolonged catheterization

• Prompt removal of intravascular devices when no longer required

Ochrobactrum anthropi vs. Other Nonfermenting Gram-Negative Bacilli

Ochrobactrum anthropi

→ Environmental organism

→ Rare opportunistic pathogen

→ Central venous catheter bacteremia is characteristic

→ May show multidrug resistance

→ Susceptibility-guided treatment is important

Pseudomonas aeruginosa

→ Much more common opportunistic pathogen

→ Pneumonia, bacteremia, burns, wounds, UTIs, device infections

→ Characteristic pigment and other microbiologic features

Stenotrophomonas maltophilia

→ Healthcare-associated opportunist

→ Often associated with devices and immunocompromised patients

→ Notable intrinsic antimicrobial resistance

→ TMP-SMX is a classic therapeutic association

High-Yield Clinical Pattern

Rare environmental Gram-negative bacillus

• ●

Hospitalized or immunocompromised patient

• ●

Central venous catheter

• ●

Catheter-related bacteremia

→ Think Ochrobactrum anthropi

Exam Essentials

Organism: Ochrobactrum anthropi

Type: Aerobic Gram-negative bacillus

Clinical behavior: Opportunistic environmental pathogen

Incubation period: Unknown

Frequency: Rare human pathogen

Reservoir: Various environmental sources

Major infection: Central venous catheter-related bacteremia

Other infections: Peritonitis and septic arthritis

Major risk factor: Indwelling medical device

Diagnosis: Culture

Source treatment: Trimethoprim–sulfamethoxazole

Additional source options: Imipenem, aminoglycosides, fluoroquinolones

Resistance: Variable; resistance to multiple β-lactams may occur

Treatment principle: Susceptibility-guided antimicrobial therapy

Device-associated disease: Consider catheter/device removal when indicated

Prevention: Aseptic catheter care and minimizing unnecessary indwelling devices

Key clinical pearl: Ochrobactrum anthropi is a rare environmental Gram-negative bacillus with a strong association with central venous catheter-related bacteremia. When it is repeatedly isolated from blood in a patient with an indwelling catheter, consider it a true opportunistic pathogen, obtain susceptibility testing, and address the infected device as part of source control.

Infectious Disease and Microbiology – Necator americanus

Overview

Necator americanus is an intestinal hookworm and a soil-transmitted nematode helminth that infects humans. Adult worms attach to the mucosa of the small intestine and feed on blood, which can lead to chronic intestinal blood loss and iron-deficiency anemia, particularly in patients with heavy or prolonged infections.

Infection is acquired when infective larvae in contaminated soil penetrate intact skin, commonly through bare feet. The larvae subsequently migrate through the bloodstream to the lungs, ascend the respiratory tract, are swallowed, and mature into adult worms in the intestine.

Classification

Genus: Necator

Species: Necator americanus

Type: Nematode helminth (roundworm)

Group: Hookworm

Disease: Hookworm infection

Microbiologic Characteristics

N. americanus is a:

• Nematode

• Soil-transmitted helminth

• Intestinal blood-feeding parasite

• Human hookworm

The major pathogenic effect results from:

Chronic intestinal blood loss

caused by adult worms feeding on the intestinal mucosa.

Epidemiology

N. americanus is particularly associated with:

Tropical and subtropical regions

Historically, it has been especially important in the:

Americas

although human hookworm infections occur in multiple tropical and subtropical regions worldwide.

Environmental Requirements

Transmission is favored by:

• Warm climates

• Moist soil

• Poor sanitation

• Soil contamination with human feces

• Walking barefoot

• Inadequate disposal of human waste

Transmission

Infected humans pass:

Hookworm eggs in feces

The eggs hatch in suitable soil and develop through larval stages until they become infective:

Filariform larvae

These larvae can penetrate human skin.

Life Cycle

Eggs passed in human feces

↓

Eggs hatch in warm, moist soil

↓

Rhabditiform larvae

↓

Development into:

Infective filariform larvae

↓

Larvae penetrate intact human skin

↓

Enter bloodstream

↓

Travel to lungs

↓

Enter alveoli

↓

Ascend bronchial tree and trachea

↓

Are swallowed

↓

Reach small intestine

↓

Develop into adult hookworms

↓

Attach to intestinal mucosa and feed on blood

↓

Eggs passed in feces

High-Yield Life-Cycle Pattern

Filariform larva

→ Infective stage

Skin penetration

→ Entry into humans

Lung migration

→ Transient respiratory manifestations

Small intestine

→ Adult worms

Eggs in stool

→ Diagnostic stage

Skin Manifestations

The initial penetration of infective larvae through the skin can produce:

Localized pruritus and inflammation

This reaction is commonly called:

Ground itch

It often occurs on the feet or other areas that directly contact contaminated soil.

High-Yield Skin Pattern

Barefoot exposure to contaminated soil

• ●

Pruritic lesion on foot

→ Think hookworm larval penetration

Pulmonary Migration

After entering the circulation, larvae migrate to the:

Lungs

During this stage, patients may experience:

• Cough

• Shortness of breath

• Throat irritation

• Transient pulmonary symptoms

Pulmonary migration can occasionally be accompanied by eosinophilic inflammatory responses.

Migration Pattern

Skin

↓

Bloodstream

↓

Lungs

↓

Trachea/pharynx

↓

Swallowed

↓

Small intestine

This migration pathway is highly important for examinations.

Intestinal Infection

Adult N. americanus worms attach to the:

Small intestinal mucosa

and consume blood.

Light infections may be:

Asymptomatic

Heavier infections can produce clinically significant gastrointestinal and hematologic disease.

Clinical Manifestations

Possible manifestations include:

• Iron-deficiency anemia

• Diarrhea

• Abdominal cramping

• Anorexia

• Fatigue

• Weakness

The severity generally increases with the number of worms and duration of infection.

Iron-Deficiency Anemia

The most important complication of chronic hookworm infection is:

Iron-deficiency anemia

Adult worms feed on blood and cause continuing intestinal blood loss.

Pathogenesis of Anemia

Adult hookworms attach to intestinal mucosa

↓

Blood feeding

↓

Chronic gastrointestinal blood loss

↓

Progressive iron depletion

↓

Iron-deficiency anemia

↓

Fatigue, weakness and pallor

Heavy Infection

Patients with a large worm burden may develop substantial anemia.

Children are particularly vulnerable to the consequences of chronic infection because persistent anemia and nutritional deficiencies can interfere with:

• Growth

• Physical development

• Cognitive performance

Eosinophilia

As with many helminth infections involving tissue migration:

Peripheral eosinophilia

may occur, particularly during larval migration.

Eosinophilia therefore provides a useful clue when compatible exposure and gastrointestinal or pulmonary findings are present.

Diagnosis

Diagnosis is primarily made through:

Microscopic examination of stool for hookworm eggs

Stool Microscopy

The characteristic finding is:

Hookworm ova in feces

Routine microscopy generally cannot reliably distinguish N. americanus eggs from those of other common human hookworms based on egg morphology alone.

Diagnostic Pattern

Tropical/subtropical exposure

• ●

Barefoot soil contact

• ●

Iron-deficiency anemia

• ●

Eosinophilia

• ●

Hookworm eggs in stool

→ Think hookworm infection

→ Consider Necator americanus

Treatment

The source recommends:

Mebendazole 100 mg orally every 12 hours for 3 days

as a primary treatment regimen.

Additional Treatment

The source also lists:

Albendazole 400 mg orally as a single dose

as an alternative treatment.

Pyrantel Pamoate

The source notes that:

Pyrantel pamoate

may be used in children for:

3 days

depending on the clinical setting.

Treatment of Heavy Infection

The source recommends that patients with substantial anemia caused by a heavy parasite burden may receive:

A second treatment cycle 1–2 weeks after the initial course

Clinical management should also address the consequences of chronic blood loss.

Management of Anemia

When hookworm infection has caused significant iron deficiency, antiparasitic treatment alone may not immediately correct the hematologic abnormality.

Management may therefore include:

Anthelmintic treatment

• ●

Iron replacement when indicated

• ●

Correction of associated nutritional deficiencies

Necator americanus vs. Ancylostoma duodenale

The two classic human hookworms are:

Necator americanus

and

Ancylostoma duodenale

Both can cause:

• Skin penetration

• Pulmonary larval migration

• Intestinal infection

• Chronic blood loss

• Iron-deficiency anemia

• Hookworm eggs in stool

Important Morphologic Difference

Necator americanus

→ Buccal capsule contains cutting plates

Ancylostoma duodenale

→ Buccal capsule contains teeth

This is a classic parasitology distinction.

Hookworm vs. Strongyloides

Hookworm – Necator americanus

→ Filariform larvae penetrate skin

→ Pulmonary migration

→ Adults inhabit small intestine

→ Eggs typically detected in stool

→ Major complication: iron-deficiency anemia

Strongyloides stercoralis

→ Filariform larvae penetrate skin

→ Pulmonary migration

→ Intestinal infection

→ Larvae rather than eggs typically detected in stool

→ Autoinfection occurs

→ Hyperinfection can occur with immunosuppression

High-Yield Clinical Pattern

Patient from tropical/subtropical region

• ●

Barefoot exposure to contaminated soil

• ●

Pruritic “ground itch”

• ●

Transient cough during larval migration

• ●

Chronic iron-deficiency anemia

• ●

Hookworm eggs in stool

→ Think Necator americanus

Exam Essentials

Organism: Necator americanus

Type: Nematode helminth

Group: Hookworm

Distribution: Tropical and subtropical regions

Transmission: Filariform larvae penetrate intact skin

Major risk: Barefoot contact with fecally contaminated soil

Initial skin manifestation: Ground itch

Migration: Skin → bloodstream → lungs → trachea → swallowed → small intestine

Pulmonary symptoms: Cough and occasional dyspnea

Adult location: Small intestine

Major pathogenic mechanism: Blood feeding and intestinal blood loss

Major complication: Iron-deficiency anemia

Possible laboratory clue: Eosinophilia

Diagnosis: Hookworm eggs in stool

First-line drugs: Albendazole or mebendazole

Source mebendazole regimen: 100 mg orally every 12 hours for 3 days

Source albendazole regimen: 400 mg orally once

Heavy infection: Treat parasitic infection and correct iron deficiency

Classic morphology: N. americanus has cutting plates

Key clinical pearl: Necator americanus is a soil-transmitted hookworm acquired when infective filariform larvae penetrate the skin, often through bare feet. Remember the sequence “ground itch → lung migration with cough → small-intestinal blood feeding → iron-deficiency anemia,” with diagnosis made by identifying hookworm eggs in stool.

Infectious Disease and Microbiology – Nanophyetus salmincola

Overview

Nanophyetus salmincola is a small intestinal trematode (fluke) that causes nanophyetiasis, a foodborne parasitic infection acquired by eating raw or inadequately cooked infected fish, particularly salmonids.

Human infections have been reported primarily from the Pacific Northwest of the United States. Infection involves the gastrointestinal tract and is often mild, although patients may develop nonspecific gastrointestinal symptoms.

Classification

Genus: Nanophyetus

Species: N. salmincola

Type: Trematode helminth (fluke)

Disease: Nanophyetiasis

Microbiologic Characteristics

N. salmincola is a:

• Trematode

• Foodborne intestinal parasite

• Small fluke that develops in the gastrointestinal tract after ingestion of infective larvae

The infective stage for humans is the:

Metacercaria

which is present in infected fish.

Epidemiology

Human infection with N. salmincola has been reported particularly from:

Northwestern United States

The parasite is associated with freshwater and anadromous fish, especially:

Salmonids

Transmission

Humans acquire infection by consuming:

Raw or inadequately cooked infected fish

The source particularly emphasizes:

• Raw salmon

• Incompletely cooked salmon

• Smoked salmon that has not been adequately processed to kill the parasite

Life Cycle

The life cycle involves aquatic intermediate hosts.

Eggs reach freshwater

↓

Freshwater snail serves as first intermediate host

↓

Larval development

↓

Cercariae leave snail

↓

Fish becomes second intermediate host

↓

Metacercariae develop in fish tissues

↓

Human eats raw or undercooked infected fish

↓

Adult flukes develop in intestine

↓

Eggs are passed in stool

High-Yield Transmission Pattern

Pacific Northwest

• ●

Raw or undercooked salmon

• ●

Intestinal fluke infection

→ Think Nanophyetus salmincola

Nanophyetiasis

Human infection is called:

Nanophyetiasis

The adult parasites inhabit the:

Small intestine

and may produce gastrointestinal symptoms.

Clinical Manifestations

Symptoms are generally nonspecific and may include:

• Abdominal discomfort

• Abdominal pain

• Diarrhea

• Nausea

• Other gastrointestinal complaints

The severity of symptoms may depend partly on the parasite burden.

Asymptomatic Infection

Some infections may produce:

Few or no symptoms

Therefore, diagnosis may occasionally occur after eggs are identified during stool examination rather than because of a distinctive clinical syndrome.

Important Salmon Association

The most useful epidemiologic clue is:

Consumption of raw or inadequately cooked salmon or related fish

This exposure is particularly important in patients from or traveling through the:

Pacific Northwest

Diagnosis

Diagnosis is made by:

Parasitologic examination of stool specimens

The characteristic finding is:

N. salmincola eggs

Egg Morphology

The source describes eggs measuring approximately:

64–97 μm long × 43–55 μm wide

Recognition of the eggs in stool establishes the parasitologic diagnosis.

Diagnostic Pattern

Nonspecific gastrointestinal symptoms

• ●

Raw salmon exposure

• ●

Pacific Northwest

• ●

Trematode eggs in stool

→ Nanophyetus salmincola

Treatment

The source recommends:

Praziquantel

at a total dose of:

60 mg/kg/day

divided into:

3 doses for 1 day

Praziquantel is therefore the principal antiparasitic treatment described for human nanophyetiasis.

Treatment Principle

Confirmed intestinal N. salmincola infection

↓

Praziquantel

↓

Eradication of intestinal trematodes

↓

Resolution of gastrointestinal manifestations

Prevention

The primary preventive measure is:

Avoid eating raw or inadequately cooked infected fish

particularly salmon and related species from endemic areas.

Food Safety

Risk can be reduced through:

• Thorough cooking of salmon

• Avoiding raw infected fish

• Avoiding inadequately processed fish

• Recognizing that some traditional smoking processes may not reliably eliminate parasites

Nanophyetus vs. Heterophyes vs. Metagonimus

Nanophyetus salmincola

→ Intestinal trematode

→ Raw salmon/fish

→ Pacific Northwest association

→ Nonspecific gastrointestinal disease

Heterophyes heterophyes

→ Minute intestinal fluke

→ Raw/undercooked fish

→ Middle East and parts of Asia

→ Usually mild intestinal disease

Metagonimus yokogawai

→ Small intestinal fluke

→ Raw freshwater fish

→ Primarily East Asian distribution

→ Diarrhea and abdominal discomfort

All three are foodborne intestinal trematodes, but geographic and fish-exposure histories help distinguish them.

Important Veterinary Distinction

N. salmincola has an additional well-known association in veterinary medicine: the fluke can carry a bacterial pathogen responsible for salmon poisoning disease in dogs.

This veterinary syndrome should not be confused with ordinary human nanophyetiasis.

For human infection, the primary concern is the:

Intestinal trematode itself

High-Yield Clinical Pattern

Patient from the Pacific Northwest

• ●

Raw, undercooked, or inadequately smoked salmon

• ●

Nonspecific gastrointestinal symptoms

• ●

Trematode eggs in stool

→ Think Nanophyetus salmincola

→ Nanophyetiasis

Exam Essentials

Organism: Nanophyetus salmincola

Type: Trematode helminth

Disease: Nanophyetiasis

Major geographic association: Pacific Northwest United States

Transmission: Eating raw or inadequately cooked infected fish

Classic food association: Salmon

Infective stage: Metacercaria in fish

First intermediate host: Freshwater snail

Second intermediate host: Fish

Site of human infection: Small intestine

Clinical disease: Nonspecific gastrointestinal symptoms

Diagnosis: Eggs in stool

Egg size in source: 64–97 × 43–55 μm

Treatment: Praziquantel 60 mg/kg/day divided into 3 doses for 1 day

Prevention: Thoroughly cook fish and avoid raw or inadequately processed salmon

Key clinical pearl: Nanophyetus salmincola is a foodborne intestinal trematode classically associated with the Pacific Northwest and consumption of raw or inadequately cooked salmon. Patients typically have nonspecific gastrointestinal symptoms, diagnosis is made by finding eggs in stool, and praziquantel is the treatment of choice.

Infectious Disease and Microbiology – Naegleria fowleri

Overview

Naegleria fowleri is a free-living amoeba that causes primary amebic meningoencephalitis (PAM), a rare but extremely aggressive infection of the central nervous system.

The organism is associated particularly with warm freshwater exposure. Infection occurs when contaminated water enters the nose, allowing the amoeba to migrate along the olfactory nerves into the brain. The disease progresses rapidly and is usually fatal.

Classification

Genus: Naegleria

Species: Naegleria fowleri

Organism type: Free-living amoeba

Major disease: Primary amebic meningoencephalitis (PAM)

Microbiologic Characteristics

N. fowleri is an environmental amoeba rather than an obligate human parasite.

It has three major forms:

• Trophozoite

• Flagellate form

• Cyst

The trophozoite is the invasive and replicating form responsible for human CNS disease.

Environmental Reservoir

N. fowleri can occur in:

• Warm freshwater

• Lakes

• Rivers

• Hot springs

• Warm freshwater sediments

• Soil

It grows particularly well in warm environmental conditions.

Important Water Association

The classic exposure is:

Swimming or diving in warm freshwater

especially when water is forced into the:

Nasal cavity

Transmission

Human infection occurs when water containing N. fowleri enters the:

Nose

The organism then penetrates the nasal mucosa and migrates toward the brain.

Pathogenesis

Contaminated warm freshwater enters nose

↓

Amoebae contact olfactory mucosa

↓

Penetration through nasal tissue

↓

Migration along olfactory nerves

↓

Passage through the cribriform plate

↓

Brain invasion

↓

Fulminant meningoencephalitis

Critical Transmission Point

Naegleria fowleri infection is acquired through the NOSE—not by simply drinking contaminated water.

This is one of the most important high-yield facts.

Incubation Period

The source describes an incubation period of:

1–3 days

More broadly, symptoms usually develop within several days after exposure.

Once neurologic illness begins, progression can be extraordinarily rapid.

Primary Amebic Meningoencephalitis

The characteristic disease is:

Primary amebic meningoencephalitis (PAM)

PAM is an acute, rapidly progressive infection involving the:

Brain and meninges

Clinical Manifestations

Early manifestations can resemble acute bacterial meningitis and include:

• Severe headache

• High fever

• Nausea

• Vomiting

• Neck stiffness

Neurologic deterioration may rapidly follow.

Progressive Neurologic Disease

As CNS infection advances, patients may develop:

• Altered mental status

• Confusion

• Seizures

• Hallucinations

• Ataxia

• Cranial nerve abnormalities

• Coma

The disease may progress from initial symptoms to profound neurologic deterioration within only a few days.

High-Yield Clinical Pattern

Previously healthy child or young adult

• ●

Recent swimming/diving in warm freshwater

• ●

Water entered the nose

• ●

Acute severe meningitis/encephalitis

• ●

Rapid neurologic deterioration

→ Think Naegleria fowleri

→ Primary amebic meningoencephalitis

Diagnosis

Diagnosis must be performed urgently because PAM progresses extremely rapidly.

The source emphasizes:

Fresh examination of cerebrospinal fluid (CSF)

and staining with:

• Giemsa stain

• Wright stain

Fresh CSF Examination

A fresh wet preparation of CSF may demonstrate:

Motile trophozoites

The presence of actively moving amoebae can provide an important diagnostic clue.

Important Microscopy Point

The diagnostic form in human tissue and CSF is primarily the:

Trophozoite

Cysts are not typically the major form encountered in human CNS tissue.

CSF Findings

CSF findings may resemble those of:

Acute bacterial meningitis

with abnormalities such as:

• Elevated opening pressure

• Neutrophilic pleocytosis

• Elevated protein

• Low glucose

This similarity can initially lead to misdiagnosis as bacterial meningitis.

Molecular Diagnosis

Modern diagnosis can include:

PCR/NAAT

on CSF or tissue specimens.

Molecular testing can provide specific confirmation of N. fowleri infection.

Culture

The source also lists:

Culture using specialized media

as a diagnostic method.

However, because the disease progresses so rapidly, treatment should not be delayed while awaiting culture confirmation when PAM is strongly suspected.

Treatment

The source states that no reliably effective treatment was known and describes combinations including:

Intravenous and intrathecal amphotericin B

with other agents.

This reflects the historically extremely poor prognosis of PAM.

Modern Treatment Concept

Because PAM is exceptionally rare, evidence is based largely on case reports and survivor experience rather than randomized clinical trials.

Management generally requires:

Immediate multidrug anti-amebic therapy

• ●

Aggressive neurocritical care

Treatment regimens have included amphotericin B together with other agents, with miltefosine incorporated into some contemporary multidrug approaches.

Treatment should involve urgent consultation with infectious-disease and specialized public-health experts.

Importance of Early Treatment

The major therapeutic principle is:

Do not wait for definitive confirmation when clinical suspicion is very high.

Because PAM progresses rapidly, even a short delay may substantially reduce the chance of survival.

Prognosis

Primary amebic meningoencephalitis has an:

Extremely high case-fatality rate

Survival is rare, although documented survivors demonstrate that successful treatment is possible, particularly with:

• Very early recognition

• Rapid initiation of combination therapy

• Aggressive control of cerebral edema and intracranial pressure

Prevention

Prevention focuses on preventing potentially contaminated warm freshwater from entering the:

Nose

during recreational water activities.

Preventive Measures

Risk can be reduced by:

• Using nose clips during relevant freshwater activities

• Keeping the head above water in warm freshwater when appropriate

• Avoiding disturbing sediment in very warm shallow freshwater

• Following appropriate water-treatment practices

Nasal Rinsing

Another important prevention principle concerns:

Nasal irrigation

Water used for sinus or nasal rinsing should be appropriately safe, such as water that has been distilled, sterile, or appropriately boiled and cooled, rather than untreated water that could contain microorganisms.

Naegleria vs. Acanthamoeba vs. Balamuthia

Naegleria fowleri

→ Warm freshwater

→ Enters through nose

→ Olfactory nerve/cribriform plate

→ Primary amebic meningoencephalitis

→ Acute, fulminant course

→ Often previously healthy individuals

Acanthamoeba

→ Environmental exposure

→ Granulomatous amebic encephalitis

→ Usually slower/subacute course

→ Keratitis strongly associated with contact lenses

Balamuthia mandrillaris

→ Soil/environment

→ Granulomatous amebic encephalitis

→ Subacute/chronic course

→ Skin lesions may precede CNS disease

→ Can occur in immunocompetent or immunocompromised patients

High-Yield Distinction

Naegleria

→ Acute + warm freshwater + nose + fulminant PAM

Acanthamoeba/Balamuthia

→ Usually subacute/chronic granulomatous encephalitis

Exam Essentials

Organism: Naegleria fowleri

Type: Free-living amoeba

Environmental reservoir: Warm freshwater and soil

Major exposure: Swimming/diving in warm freshwater

Portal of entry: NOSE

Route to CNS: Olfactory nerves → cribriform plate → brain

Major disease: Primary amebic meningoencephalitis (PAM)

Course: Acute, rapidly progressive and fulminant

Early symptoms: Severe headache, fever, nausea/vomiting, neck stiffness

Late manifestations: Confusion, seizures, coma

CSF: Can resemble bacterial meningitis

Microscopy: Motile trophozoites in fresh CSF

Diagnosis: Fresh CSF microscopy, PCR/NAAT, specialized culture

Historical treatment: Amphotericin B-based combination therapy

Modern principle: Urgent multidrug therapy, potentially including miltefosine, plus aggressive neurocritical care

Prognosis: Extremely high mortality

Prevention: Prevent warm freshwater from entering the nose

Key clinical pearl: Think Naegleria fowleri when a previously healthy person develops rapidly progressive meningitis or encephalitis within days of swimming or diving in warm freshwater. The organism enters through the nose, crosses the cribriform plate along the olfactory pathway, and causes fulminant primary amebic meningoencephalitis; urgent diagnosis and immediate combination therapy are critical.

Infectious Disease and Microbiology – Myiasis Agents

Overview

Myiasis is an infestation of humans or other vertebrates by the larval stages (maggots) of certain dipterous flies. The larvae may invade or temporarily inhabit the skin, subcutaneous tissues, wounds, or body cavities, where they feed on living or necrotic tissue or body fluids.

Disease is particularly associated with tropical and subtropical regions, although cases can occur elsewhere, especially after travel to endemic areas.

Classification

Type: Arthropod infestation

Organisms: Larvae of flies belonging to the order Diptera

Important genera capable of causing human myiasis include:

• Calliphora

• Chrysomya

• Cochliomyia

• Cordylobia

• Dermatobia

• Gasterophilus

• Lucilia

• Phormia

• Sarcophaga

• Wohlfahrtia

Numerous species within these genera can produce myiasis.

Microbiologic Characteristics

The causative organisms are:

Fly larvae (maggots)

and therefore are:

Arthropods

rather than bacteria, fungi, protozoa, or helminths.

Adult flies generally deposit eggs or larvae directly or indirectly onto the host, after which the larvae develop within or upon human tissues.

Important Terminology

Myiasis

= infestation of living humans or animals by dipterous fly larvae

The word describes the clinical infestation rather than one particular species of fly.

Epidemiology

Myiasis occurs most frequently in:

Tropical and subtropical climates

Risk depends heavily on the responsible fly species and its geographic distribution.

Risk Factors

Potential risk factors include:

• Residence in or travel to endemic regions

• Exposure to biting insects

• Sleeping outdoors

• Open wounds

• Poor wound care

• Contact with livestock or animals

• Inadequate protection from flies

Some forms occur in completely healthy travelers after ordinary outdoor exposure.

Transmission

Transmission varies considerably among fly species.

Some flies:

Deposit eggs directly onto skin or wounds

while others use an indirect mechanism.

For example, some species attach their eggs to another arthropod, such as a mosquito, which subsequently transports the eggs to human skin.

Dermatobia hominis

Dermatobia hominis, the human botfly, is an important cause of:

Furuncular myiasis

in tropical regions of the Americas.

Its eggs can be transported to humans by blood-feeding insects.

Dermatobia Transmission Pattern

Adult botfly

↓

Eggs attached to mosquito or another insect

↓

Mosquito contacts human skin

↓

Larva enters skin

↓

Furuncle-like lesion develops

↓

Larva matures beneath skin

Cordylobia Species

Cordylobia anthropophaga, sometimes called the tumbu fly, is another important cause of furuncular myiasis, particularly in:

Sub-Saharan Africa

Larvae may penetrate skin after contact with contaminated soil or clothing.

Clinical Forms of Myiasis

Myiasis can be classified according to the anatomical site involved.

Important forms include:

• Furuncular myiasis

• Wound myiasis

• Migratory myiasis

• Nasal myiasis

• Aural myiasis

• Ophthalmic myiasis

• Intestinal or other cavity-associated forms

Furuncular Myiasis

The classic presentation is a:

Furuncle-like skin lesion containing a developing larva

The lesion typically has a central opening that allows the larva to obtain oxygen.

Clinical Manifestations

Patients may experience:

• Local swelling

• Erythema

• Pain

• Pruritus

• Serous or bloody drainage

• Sensation of movement within the lesion

• Visible central opening

Occasionally, part of the larva may become visible through the opening.

High-Yield Clinical Pattern

Traveler returning from a tropical region

• ●

Persistent boil-like lesion

• ●

Central punctum

• ●

Sensation of movement

→ Think furuncular myiasis

Wound Myiasis

Some fly species deposit eggs or larvae into:

Open wounds

The larvae subsequently develop within the wound.

Clinical manifestations may include:

• Visible larvae

• Increased wound drainage

• Local inflammation

• Tissue destruction

• Secondary bacterial infection

Certain species can invade viable tissue and produce substantial tissue damage.

Local Inflammation

As described in the source, larvae may parasitize:

Skin and subcutaneous tissues

resulting in:

Local inflammatory reactions

The severity ranges from a small localized lesion to extensive tissue destruction depending on the species and type of myiasis.

Diagnosis

The primary diagnosis is made by:

Identification of larvae within the affected area

A careful physical examination is often sufficient to recognize the infestation.

Species Identification

When necessary, the removed larva can be examined morphologically to identify the causative species.

Features useful for identification may include:

• Body segmentation

• Spines

• Respiratory structures

• Posterior spiracles

• Other characteristic larval structures

Geographic exposure also provides an important diagnostic clue.

Imaging

Imaging is generally unnecessary for superficial disease.

However, ultrasound or other imaging can occasionally help demonstrate a larva when the diagnosis is uncertain or the organism is located relatively deeply.

Treatment

The major goal is:

Complete removal of the larva

without leaving significant larval material within the tissue.

Occlusion Technique

For appropriate forms of furuncular myiasis, the source describes occlusion of the larva’s respiratory opening using:

Petroleum jelly (Vaseline)

The principle is:

Cover central breathing opening

↓

Reduce larval oxygen supply

↓

Larva moves toward the surface

↓

Larva can emerge or become easier to extract

Removal with Forceps

Once accessible, the larva may be:

Carefully removed with forceps

The source cautions against forceful extraction.

This is particularly relevant when the larva is tightly anchored by backward-facing spines.

Why Forceful Removal Should Be Avoided

Forceful extraction may:

• Rupture the larva

• Leave larval fragments within the wound

• Increase inflammation

• Cause additional tissue injury

Therefore, removal should be controlled and complete.

Surgical Removal

When occlusion or gentle extraction is unsuccessful:

Surgical removal

may be necessary.

A small incision can enlarge the opening and permit intact extraction of the larva.

Wound Myiasis Treatment

For wound-associated infestation, management may require:

Mechanical removal of all larvae

• ●

Wound irrigation and debridement

• ●

Appropriate wound care

Secondary bacterial infection should be treated when clinically present.

Treatment Principle

Furuncular myiasis

↓

Identify breathing opening

↓

Occlusion may encourage larval emergence

↓

Gentle complete extraction

↓

If unsuccessful:

Surgical removal

Prevention

Prevention is particularly important when traveling in endemic tropical regions.

Measures include:

• Protective clothing

• Insect repellents

• Appropriate mosquito/fly control

• Covering open wounds

• Proper wound hygiene

• Avoiding exposure of wounds to flies

• Appropriate handling of clothing in areas where particular myiasis-producing flies occur

Myiasis vs. Cutaneous Larva Migrans

Myiasis

→ Fly larvae

→ Arthropods

→ Furuncle-like or wound-associated lesions

→ Larva may be directly visible

→ Central breathing pore may occur

Cutaneous larva migrans

→ Usually animal hookworm larvae

→ Nematode helminths

→ Characteristic serpiginous migrating tracks

→ No mature fly larva within a furuncular cavity

Myiasis vs. Tungiasis

Myiasis

→ Dipterous fly larvae invade tissue

Tungiasis

→ Adult female Tunga penetrans flea embeds within skin

Both are arthropod-related skin infestations but involve completely different organisms.

High-Yield Clinical Pattern

Tropical or subtropical exposure

• ●

Boil-like inflammatory skin lesion

• ●

Central opening

• ●

Visible or moving larva

→ Think MYIASIS

→ Dipterous fly larva

Exam Essentials

Disease: Myiasis

Cause: Larvae of dipterous flies

Organism type: Arthropod

Important genera: Dermatobia, Cordylobia, Cochliomyia, Chrysomya, Lucilia, Sarcophaga, Wohlfahrtia and others

Distribution: Especially tropical and subtropical regions

Major tissue involvement: Skin and subcutaneous tissue

Classic form: Furuncular myiasis

Classic lesion: Boil-like lesion with central respiratory opening

Other form: Wound myiasis

Diagnosis: Direct identification of larvae

Treatment principle: Complete larval removal

Source technique: Occlusion with petroleum jelly followed by gentle extraction

Important caution: Avoid forceful removal

If extraction fails: Surgical removal

Wound disease: Remove larvae, debride/clean wound, and manage secondary infection if present

Prevention: Fly avoidance, protective clothing, wound coverage, and appropriate hygiene

Key clinical pearl: Myiasis is an infestation by dipterous fly larvae. The classic clue is a traveler from a tropical region with a persistent furuncle-like lesion containing a central breathing pore and sometimes a sensation of movement. Treatment centers on complete, gentle removal of the larva; occlusion of the breathing opening can facilitate extraction, while forceful removal should be avoided.

Infectious Disease and Microbiology – Mycoplasma Species

Overview

Mycoplasma species are extremely small, pleomorphic bacteria that lack a cell wall. This absence of peptidoglycan is their defining microbiologic feature and explains why β-lactam antibiotics such as penicillins and cephalosporins are ineffective.

Many Mycoplasma species exist as commensal organisms of human mucosal surfaces. Clinically, Mycoplasma pneumoniae is most important as a respiratory pathogen, while M. genitalium and M. hominis are associated primarily with the genitourinary tract.

Classification

Genus: Mycoplasma

Species listed in the source include:

• M. buccale

• M. faucium

• M. felis

• M. genitalium

• M. hominis

• M. laidlawii

• M. lipophilum

• M. oculi

• M. orale

• M. penetrans

• M. pirum

• M. pneumoniae

• M. primatum

• M. salivarium

• M. spermatophilum

• M. urealyticum

Taxonomic Note

The organism historically called:

Mycoplasma urealyticum

is now classified as:

Ureaplasma urealyticum

It shares the important characteristic of lacking a conventional bacterial cell wall.

Microbiologic Characteristics

Mycoplasma species are:

• Very small bacteria

• Without a cell wall

• Pleomorphic

• Surrounded only by a cell membrane

• Poorly visualized by conventional Gram staining

Because there is no rigid peptidoglycan layer, these organisms can assume variable shapes.

The Most Important Feature – No Cell Wall

The absence of a cell wall has major therapeutic implications.

Antibiotics that inhibit cell-wall synthesis have no appropriate target.

Therefore:

Penicillins

• ●

Cephalosporins

• ●

Other β-lactam antibiotics

→ Ineffective against Mycoplasma

High-Yield Microbiology Pattern

Extremely small bacterium

• ●

No cell wall

• ●

Pleomorphic

• ●

Does not stain well with Gram stain

• ●

Intrinsically resistant to β-lactams

→ Think Mycoplasma

Epidemiology

Mycoplasma species occur:

Worldwide

Many are commensal organisms that may be recovered from healthy human mucosal surfaces.

Therefore, isolation of some species does not necessarily establish that they are causing disease.

Major Sites

M. pneumoniae

→ Respiratory tract

M. hominis

→ Genitourinary tract

M. genitalium

→ Genitourinary tract and sexually transmitted infection

Mycoplasma pneumoniae

M. pneumoniae is the major respiratory pathogen in this genus and is a classic cause of:

Atypical pneumonia

It also causes several upper and lower respiratory tract syndromes.

Incubation Period

The source gives an incubation period of:

6–32 days

for clinical syndromes caused by M. pneumoniae.

The relatively long incubation period allows gradual transmission within households and other close-contact populations.

Transmission

M. pneumoniae is transmitted mainly through:

Respiratory droplets

Close and prolonged interpersonal contact facilitates transmission.

Epidemiologic Pattern

Respiratory infection is particularly common among:

Older children, adolescents, and young adults

The source emphasizes patients approximately:

10–40 years old

Infections can occur:

• Sporadically

• Endemically

• In outbreaks or epidemics

Disease occurs throughout the year.

Outbreak Settings

Transmission may be facilitated in:

• Schools

• Dormitories

• Military barracks

• Households

• Other crowded living environments

Respiratory Infections

M. pneumoniae can cause:

• Pneumonia

• Bronchitis

• Tracheobronchitis

• Pharyngitis

• Sinusitis

• Myringitis

Atypical Pneumonia

The classic respiratory syndrome is:

Atypical or “walking” pneumonia

Patients often develop a gradually progressive illness rather than the abrupt presentation typical of some bacterial pneumonias.

Clinical Manifestations

Typical manifestations include:

• Fever

• Malaise

• Headache

• Sore throat

• Persistent dry cough

• Bronchitis

• Pneumonia

The cough can persist for a prolonged period.

High-Yield Respiratory Pattern

Adolescent or young adult

• ●

Gradual respiratory illness

• ●

Persistent dry cough

• ●

Atypical pneumonia

→ Think Mycoplasma pneumoniae

Extrapulmonary Manifestations

Although M. pneumoniae primarily causes respiratory disease, rare extrapulmonary complications include:

• Hemolytic anemia

• Pericarditis

• Myocarditis

• Meningoencephalitis

• Erythema multiforme

• Hepatitis

Some complications may result from immune-mediated mechanisms.

Cold Agglutinin Hemolytic Anemia

A classic association of M. pneumoniae is:

Cold agglutinin-associated hemolytic anemia

Antibodies generated during infection can react with red blood cells at lower temperatures and produce agglutination and hemolysis.

High-Yield Association

M. pneumoniae

→ Cold agglutinins

→ Red-cell agglutination

→ Hemolytic anemia

This is an important exam association, although cold agglutinin testing is neither sufficiently sensitive nor specific to be the preferred modern diagnostic method.

Cardiac Disease

Rare cardiac manifestations include:

Myocarditis

and

Pericarditis

Neurologic Disease

Rare neurologic complications include:

• Encephalitis

• Meningitis

• Meningoencephalitis

Dermatologic Disease

M. pneumoniae may be associated with:

Erythema multiforme

and other mucocutaneous inflammatory syndromes.

Myringitis

M. pneumoniae has historically been associated with:

Bullous myringitis

However, bullous myringitis is not specific for M. pneumoniae and can occur with other respiratory pathogens.

Mycoplasma genitalium

M. genitalium is an important sexually transmitted pathogen.

It is associated with:

• Nongonococcal urethritis

• Persistent or recurrent urethritis

• Cervicitis

• Pelvic inflammatory disease

High-Yield STI Pattern

Sexually active patient

• ●

Persistent/recurrent nongonococcal urethritis

→ Consider Mycoplasma genitalium

Pelvic Inflammatory Disease

M. genitalium can infect the female reproductive tract and has been associated with:

Pelvic inflammatory disease

Persistent reproductive tract infection may potentially contribute to reproductive complications.

Mycoplasma hominis

M. hominis is primarily associated with the:

Genitourinary tract

It may be recovered as part of normal genital flora but can also participate in clinically significant infection.

Salpingitis

The source reports isolation of M. hominis from the:

• Endometrium

• Fallopian tubes

in approximately 10% of women with salpingitis.

However, because salpingitis and pelvic inflammatory disease are frequently:

Polymicrobial

the presence of M. hominis does not necessarily prove that it is the primary pathogen.

Mycoplasma fermentans

The source associates M. fermentans with uncommon reports of:

• Pneumonia

• Encephalitis

• Hepatitis

• Myopericarditis

• Sepsis

• Diarrhea

Its role in human disease is less firmly established than that of M. pneumoniae or M. genitalium.

Infertility

Some studies have suggested possible associations between genital Mycoplasma species and:

Infertility

However, interpretation is complicated because several species can colonize the genital tract without producing disease.

Therefore:

Detection does not automatically equal causation.

Diagnosis

The source lists:

• Culture

• Serology

• Detection of cold agglutinins

• PCR of respiratory specimens for M. pneumoniae

PCR and NAAT

Molecular testing is particularly useful because Mycoplasma organisms can be difficult or slow to culture.

For M. pneumoniae:

PCR/NAAT of respiratory specimens

can provide direct evidence of infection.

For M. genitalium:

NAAT is the major diagnostic approach

because routine culture is extremely difficult.

Culture

Mycoplasma species require specialized culture conditions.

Some species grow slowly, making culture less useful for rapid clinical diagnosis.

Classic Culture Appearance

A traditional microbiologic association is:

“Fried-egg” colonies

on specialized culture media.

Serology

Serology may assist in diagnosing M. pneumoniae infection, particularly when interpreted with the timing and clinical presentation.

Cold Agglutinins

The source lists:

Cryoagglutinin/cold agglutinin testing

for M. pneumoniae.

This is primarily a historical or supportive clue rather than a definitive modern diagnostic test.

Treatment

The source lists:

Doxycycline 100 mg orally every 12 hours for 7–14 days

as treatment.

Other active antibiotic classes include:

• Macrolides

• Fluoroquinolones

The appropriate drug depends on the species, clinical syndrome, patient factors, and resistance patterns.

Treatment of M. pneumoniae

The source lists:

Macrolides

or

Fluoroquinolones

as additional treatments for M. pneumoniae infection.

Doxycycline is another important active agent.

Major Treatment Principle

Because Mycoplasma lacks a cell wall:

β-lactams do NOT work.

This includes:

• Penicillin

• Amoxicillin

• Ampicillin

• Cephalosporins

• Carbapenems

Why β-Lactams Fail

β-lactam

↓

Inhibits peptidoglycan cell-wall synthesis

↓

Mycoplasma has no peptidoglycan cell wall

↓

No therapeutic target

↓

Intrinsic resistance

Mycoplasma genitalium and Resistance

M. genitalium has become particularly important because antimicrobial resistance can complicate treatment.

Resistance may involve:

Macrolides

and

Fluoroquinolones

Therefore, treatment of confirmed M. genitalium infection should follow appropriate current guideline- or resistance-guided regimens rather than assuming that all isolates will respond to the same antibiotic.

Mycoplasma pneumoniae vs. Typical Bacterial Pneumonia

M. pneumoniae

→ No cell wall

→ Atypical pneumonia

→ Gradual onset

→ Dry cough

→ Young patients/outbreak settings

→ Cold agglutinins

→ β-lactams ineffective

Streptococcus pneumoniae

→ Gram-positive diplococcus

→ Cell wall present

→ Typical community-acquired pneumonia

→ More abrupt presentation may occur

→ Productive cough may occur

→ Susceptible infections can respond to β-lactams

Mycoplasma vs. Ureaplasma

Mycoplasma

→ No cell wall

→ M. pneumoniae: respiratory disease

→ M. genitalium: urethritis/PID

→ M. hominis: genitourinary colonization/infection

Ureaplasma

→ Also lacks a cell wall

→ Primarily genitourinary

→ Characteristically hydrolyzes urea

Prevention

For respiratory M. pneumoniae infection, transmission may be reduced through:

• Respiratory hygiene

• Avoidance of prolonged close exposure to infected individuals

• Reduction of crowding when feasible

For sexually transmitted organisms such as M. genitalium:

• Condom use

• Safer sexual practices

• Appropriate evaluation and management of sexual partners

can reduce transmission.

High-Yield Clinical Pattern

Young patient

• ●

“Walking” atypical pneumonia

• ●

Persistent dry cough

• ●

Cold agglutinins

• ●

Organism without a cell wall

→ Think Mycoplasma pneumoniae

High-Yield Genitourinary Pattern

Persistent or recurrent nongonococcal urethritis

• ●

Sexual transmission

• ●

NAAT positive

→ Think Mycoplasma genitalium

Exam Essentials

Genus: Mycoplasma

Defining feature: NO CELL WALL

Morphology: Very small and pleomorphic

Gram stain: Poorly visualized

β-lactams: Intrinsically ineffective

Major respiratory species: M. pneumoniae

Major STI species: M. genitalium

Important genital species: M. hominis

M. pneumoniae incubation: 6–32 days in the source

Transmission: Respiratory droplets

Classic disease: Atypical “walking” pneumonia

Classic symptom: Persistent dry cough

Classic laboratory association: Cold agglutinins

Important complication: Hemolytic anemia

Other complications: Myocarditis, pericarditis, CNS disease, erythema multiforme, hepatitis

M. genitalium: Nongonococcal urethritis, cervicitis, PID

Diagnosis: PCR/NAAT particularly useful

Classic culture appearance: “Fried-egg” colonies

Source treatment: Doxycycline

M. pneumoniae alternatives: Macrolide or fluoroquinolone

Key therapeutic rule: Do not treat Mycoplasma with β-lactam antibiotics

Key clinical pearl: The single most important fact about Mycoplasma is that it has no cell wall, making β-lactam antibiotics ineffective. Remember M. pneumoniae for atypical “walking” pneumonia with a persistent dry cough and cold agglutinins, and M. genitalium for persistent or recurrent nongonococcal urethritis and pelvic inflammatory disease.

Infectious Disease and Microbiology – Mycobacterium bovis

Overview

Mycobacterium bovis is an aerobic, acid-fast bacillus belonging to the Mycobacterium tuberculosis complex (MTBC). It primarily causes tuberculosis in cattle but can infect humans and produce disease that is clinically similar to tuberculosis caused by M. tuberculosis.

Human infection has classically been associated with consumption of unpasteurized dairy products, although transmission can also occur through inhalation of infectious aerosols.

Classification

Genus: Mycobacterium

Species: M. bovis

Complex: Mycobacterium tuberculosis complex

Type: Acid-fast bacillus

Microbiologic Characteristics

M. bovis is:

• Aerobic

• Slender bacillus

• Acid-fast

• Nonmotile

• Non-spore-forming

• Slow-growing

Like other mycobacteria, its cell wall contains large amounts of:

Mycolic acids

which contribute to acid-fast staining and resistance to many environmental stresses.

Acid-Fastness

The lipid-rich cell wall allows M. bovis to retain certain dyes despite acid-alcohol decolorization.

Therefore:

Acid-fast bacillus

• ●

Tuberculosis-like disease

→ Consider organisms within the M. tuberculosis complex

Epidemiology

M. bovis is primarily a:

Zoonotic pathogen

Cattle represent an important reservoir, although infection can occur in several other mammalian species.

Transmission

The classic route of human infection is:

Ingestion of contaminated, unpasteurized milk or dairy products

Another important route is:

Inhalation of infectious respiratory aerosols

particularly in settings involving close exposure to infected animals.

Importance of Pasteurization

Historically, bovine tuberculosis was an important source of human disease through contaminated milk.

Widespread:

Milk pasteurization

• ●

Control of bovine tuberculosis in cattle

have greatly reduced foodborne M. bovis infection in many countries.

Pathogenesis

After entering the body, M. bovis can survive within:

Macrophages

and produce granulomatous disease similar to M. tuberculosis.

The anatomical pattern can partly reflect the route of acquisition.

Route of Infection and Disease Pattern

Ingestion of contaminated dairy products

→ Oropharyngeal or gastrointestinal exposure

→ Regional lymphatic involvement

→ Cervical lymphadenitis or gastrointestinal tuberculosis

Whereas:

Inhalation of infectious aerosols

→ Pulmonary exposure

→ Pulmonary tuberculosis

Lymphadenitis

One important manifestation is:

Tuberculous lymphadenitis

Historically, cervical lymphadenitis associated with bovine tuberculosis was sometimes referred to as:

Scrofula

especially when cervical lymph nodes were involved.

Pulmonary Infection

Aerosol transmission can result in:

Pulmonary tuberculosis

Clinical manifestations may include:

• Persistent cough

• Fever

• Night sweats

• Weight loss

• Fatigue

• Hemoptysis in advanced disease

Pulmonary M. bovis infection may be clinically difficult to distinguish from pulmonary M. tuberculosis infection without microbiologic identification.

Gastrointestinal Infection

Ingestion of contaminated unpasteurized dairy products can produce:

Gastrointestinal tuberculosis

Potential manifestations include:

• Abdominal pain

• Fever

• Weight loss

• Intestinal inflammation

• Regional lymphadenopathy

High-Yield Exposure Pattern

Tuberculosis-like illness

• ●

History of unpasteurized milk or dairy consumption

• ●

Cattle exposure

→ Consider Mycobacterium bovis

Diagnosis

The source lists:

Culture

as the primary diagnostic method.

Culture allows confirmation of mycobacterial infection and can help differentiate organisms within the M. tuberculosis complex.

Additional Diagnostic Methods

Evaluation of suspected disease may include:

• Acid-fast staining

• Mycobacterial culture

• Nucleic acid amplification testing

• Species identification

• Drug susceptibility testing

• Histopathology of affected tissue

Because treatment differs in an important way from standard M. tuberculosis therapy, species-level identification can be clinically significant.

Histopathology

Affected tissues may demonstrate:

Granulomatous inflammation

with:

Caseous necrosis

similar to tuberculosis caused by M. tuberculosis.

Acid-fast bacilli may sometimes be demonstrated within tissue specimens.

Major Drug Resistance Feature

The most important pharmacologic characteristic of M. bovis is:

Intrinsic resistance to pyrazinamide

This is a classic distinction from typical drug-susceptible M. tuberculosis.

High-Yield Resistance Pattern

Tuberculosis

• ●

M. bovis identified

→ Remember:

PYRAZINAMIDE RESISTANT

This is one of the most important exam associations for M. bovis.

Treatment

The source describes treatment using:

Isoniazid (INH)

• ●

Rifampin

• ●

Ethambutol or streptomycin

Because M. bovis is intrinsically resistant to pyrazinamide, pyrazinamide should not be relied upon as an active drug.

Duration

The source states that:

Most infections require 9 months or more of therapy

The longer duration compared with conventional pyrazinamide-containing tuberculosis regimens reflects the absence of pyrazinamide from an effective treatment regimen.

Actual therapy should be determined by susceptibility testing, disease location, severity, and current tuberculosis treatment guidance.

Treatment Principle

M. bovis tuberculosis

↓

Confirm organism and susceptibility

↓

Isoniazid + rifampin + additional active agent initially

↓

Do not count pyrazinamide as active therapy

↓

Continue an appropriately prolonged tuberculosis regimen

M. bovis vs. M. tuberculosis

Mycobacterium bovis

→ Member of M. tuberculosis complex

→ Important animal reservoir, especially cattle

→ Zoonotic

→ Unpasteurized dairy is a classic exposure

→ Can also spread by aerosols

→ Intrinsically resistant to pyrazinamide

Mycobacterium tuberculosis

→ Primarily human reservoir

→ Mainly transmitted through respiratory aerosols

→ Pulmonary disease is classic

→ Usually pyrazinamide susceptible unless acquired resistance occurs

M. bovis and BCG

An important microbiologic connection is the:

BCG vaccine

BCG was developed from an attenuated strain of:

Mycobacterium bovis

Thus:

M. bovis

→ attenuation

→ M. bovis BCG

→ Bacillus Calmette–Guérin vaccine

Prevention

Prevention of human M. bovis infection includes:

• Pasteurization of milk

• Avoidance of unpasteurized dairy products

• Control of bovine tuberculosis

• Veterinary surveillance

• Appropriate precautions when working with potentially infected animals

• Respiratory infection-control measures when infectious pulmonary disease is present

High-Yield Clinical Pattern

Tuberculosis-like disease

• ●

Unpasteurized dairy or cattle exposure

• ●

Lymphadenitis, gastrointestinal disease, or pulmonary infection

• ●

Pyrazinamide resistance

→ Think Mycobacterium bovis

Exam Essentials

Organism: Mycobacterium bovis

Genus: Mycobacterium

Complex: Mycobacterium tuberculosis complex

Type: Aerobic acid-fast bacillus

Reservoir: Primarily cattle and other animals

Disease: Zoonotic tuberculosis

Classic transmission: Unpasteurized milk/dairy products

Other transmission: Respiratory aerosols

Major infections: Lymphadenitis, pulmonary tuberculosis, gastrointestinal tuberculosis

Diagnosis: Mycobacterial culture with species identification; molecular testing may assist

Key resistance: Intrinsic pyrazinamide resistance

Source treatment: INH + rifampin + ethambutol or streptomycin

Treatment duration: Typically prolonged; source describes ≥9 months

Prevention: Milk pasteurization and control of bovine tuberculosis

Vaccine association: BCG is derived from attenuated M. bovis

Key clinical pearl: Mycobacterium bovis is a zoonotic member of the M. tuberculosis complex classically acquired from unpasteurized dairy products or infected cattle. The single most important therapeutic clue is its intrinsic resistance to pyrazinamide, while the classic preventive measure is milk pasteurization.

Infectious Disease and Microbiology – Multiceps multiceps

Overview

Multiceps multiceps is a cestode (tapeworm) helminth primarily associated with dogs. Humans are accidental intermediate hosts and acquire infection by ingesting eggs shed in dog feces.

Human infection is extremely rare but can produce coenurosis, characterized by development of larval cysts within tissues. Involvement of the central nervous system (CNS) is the most clinically important manifestation.

Classification

Genus: Multiceps

Species: M. multiceps

Type: Cestode helminth (tapeworm)

Definitive host: Dogs and other canids

Human role: Accidental intermediate host

Taxonomic Note

Multiceps multiceps has historically been used for this parasite, although it is also commonly classified within the genus Taenia as:

Taenia multiceps

The larval infection produced in intermediate hosts is called:

Coenurosis

Microbiologic Characteristics

M. multiceps is a cestode whose adult form normally inhabits the intestine of its definitive canid host.

The important infectious stage for humans is the:

Egg

After eggs are accidentally ingested, larvae can migrate through tissues and develop into characteristic cystic structures called:

Coenuri

Incubation Period

The incubation period is:

Unknown

Clinical manifestations may not become apparent until a larval cyst has enlarged sufficiently to produce local tissue effects.

Epidemiology

M. multiceps has a:

Worldwide distribution

However, human infection is:

Very rare

The parasite primarily circulates between dogs or other canids and their normal intermediate hosts.

Transmission

Humans acquire infection through:

Ingestion of eggs from dog feces

This can occur through fecal contamination of:

• Hands

• Food

• Water

• Soil

Humans therefore act as accidental hosts rather than being necessary for continuation of the parasite’s normal life cycle.

Life Cycle

Adult tapeworm in dog/canid intestine

↓

Eggs released in feces

↓

Accidental human ingestion of eggs

↓

Larvae penetrate intestinal wall

↓

Hematogenous dissemination

↓

Development of coenurus cyst in tissue

↓

Possible CNS, ocular, subcutaneous, or other tissue disease

Coenurosis

Human infection with the larval stage is called:

Coenurosis

The characteristic lesion is a:

Coenurus cyst

A coenurus differs from some other cestode larval cysts because it can contain:

Multiple protoscolices

within a single cyst.

Central Nervous System Coenurosis

The source particularly emphasizes:

CNS cyst formation

Scattered cases of cerebral coenurosis have been reported in humans.

Clinical Manifestations

Neurologic manifestations depend on the:

• Location of the cyst

• Size of the cyst

• Degree of surrounding inflammation

• Intracranial pressure

Possible manifestations include:

• Headache

• Seizures

• Focal neurologic deficits

• Visual abnormalities

• Symptoms of increased intracranial pressure

High-Yield CNS Pattern

Dog exposure

• ●

Possible fecal contamination

• ●

Cestode larval cyst in CNS

→ Consider Multiceps multiceps coenurosis

Other Forms of Coenurosis

Although CNS disease is particularly important, larval cysts may occasionally involve other tissues, producing:

• Ocular coenurosis

• Subcutaneous coenurosis

• Muscular or other tissue involvement

Clinical manifestations depend on the affected anatomical site.

Diagnosis

The source emphasizes:

Histopathologic examination of surgically removed affected tissue

Identification of characteristic parasitic structures within the cyst can establish the diagnosis.

Histopathology

Examination of an excised cyst may demonstrate:

Coenurus larval structures

with multiple developing protoscolices.

Because infection is rare, definitive diagnosis may require careful parasitologic and histopathologic evaluation.

Imaging

When CNS involvement is suspected, imaging such as:

CT or MRI

can identify cystic lesions and define their:

• Location

• Size

• Number

• Relationship to surrounding structures

Imaging alone may not reliably distinguish coenurosis from other parasitic or nonparasitic cystic lesions.

Differential Diagnosis

CNS coenurosis may need to be distinguished from:

• Neurocysticercosis due to Taenia solium

• Echinococcosis

• Brain abscess

• Primary or metastatic tumors

• Other intracranial cystic lesions

Coenurosis vs. Cysticercosis

Coenurosis – Taenia (Multiceps) multiceps

→ Dogs/canids are definitive hosts

→ Humans ingest eggs from canid fecal contamination

→ Coenurus cyst contains multiple protoscolices

→ CNS, ocular, or subcutaneous disease

Cysticercosis – Taenia solium

→ Humans ingest T. solium eggs

→ Individual cysticercus generally contains one scolex

→ Neurocysticercosis is much more common than human coenurosis

High-Yield Morphologic Distinction

Coenurus

→ Multiple protoscolices in one cyst

Cysticercus

→ Typically single invaginated scolex

This is an important parasitologic distinction.

Treatment

The primary treatment described in the source is:

Surgical removal of the cyst

whenever anatomically possible.

Surgery can provide both:

Definitive diagnosis

and

Treatment

Praziquantel

The source states that:

High-dose praziquantel (>50 mg/kg)

may also be helpful.

Because human coenurosis is exceptionally rare, evidence for antiparasitic treatment is limited and management depends heavily on cyst location and surgical feasibility.

Treatment Principle

Localized accessible coenurus cyst

↓

Surgical excision when feasible

• ●

Histopathologic confirmation

↓

Consider antiparasitic therapy in selected cases

Prevention

Prevention focuses on interrupting fecal–oral transmission from dogs and other canids.

Important measures include:

• Handwashing after handling dogs

• Avoiding food or water contaminated with dog feces

• Appropriate disposal of dog feces

• Veterinary parasite control and deworming

• Preventing dogs from consuming infected animal tissues

High-Yield Clinical Pattern

Rare cestode infection

• ●

Dog is the definitive host

• ●

Human ingests eggs from dog feces

• ●

CNS cyst containing multiple protoscolices

→ Think Multiceps multiceps (Taenia multiceps)

→ Coenurosis

Exam Essentials

Organism: Multiceps multiceps

Alternative classification: Taenia multiceps

Type: Cestode (tapeworm)

Definitive host: Dogs and other canids

Human role: Accidental intermediate host

Transmission to humans: Ingestion of eggs from dog fecal contamination

Distribution: Worldwide

Human infection: Very rare

Disease: Coenurosis

Larval lesion: Coenurus cyst

Characteristic morphology: Multiple protoscolices within a cyst

Important site: Central nervous system

Other sites: Eye, subcutaneous tissue, and other tissues

Diagnosis: Histopathology of excised tissue; imaging assists localization

Main treatment: Surgical removal when possible

Source additional treatment: High-dose praziquantel may help

Prevention: Hygiene, avoidance of dog-fecal contamination, and veterinary parasite control

Key clinical pearl: Multiceps multiceps (Taenia multiceps) is a rare dog-associated cestode that causes human coenurosis after accidental ingestion of eggs from dog feces. CNS disease is particularly important, and the characteristic coenurus cyst contains multiple protoscolices—distinguishing it from the usually single-scolex cysticercus of Taenia solium.